Details checkedStrong evidenceCheckedcompany

ReSound Enzo IA Super Power Hearing Aids

Also known as: ReSound Enzo IA, Enzo IA, Enzo IA rechargeable super-power hearing aid

GN ReSound

Primary source

Company

GN ReSound

Program Type

Device

Modality

Prescription Hearing Aid

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

Professionally fitted rechargeable super-power behind-the-ear hearing aids with app and wireless connectivity support

Confidence

88%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

United States, Europe, Global

Population

adult, prescription-hearing-aid, behind-the-ear, super-power-hearing-aid, severe-to-profound, rechargeable, auracast

Trial IDs

Mechanism

Rechargeable super-power prescription hearing-aid platform for severe-to-profound hearing loss, emphasizing high gain, feedback control, speech spotlighting in difficult environments, all-day battery life, Bluetooth LE Audio, and Auracast-ready connectivity.

Indications

Hearing Loss Sensorineural Hearing Loss Mixed Hearing Loss

Notes

Adds ReSound’s current super-power platform so the GN prescription coverage is not only Vivia/Nexia/Savi mainstream form factors and older Enzo Q pages.

Evidence & Sources

1 structured sources

company

Supports: canonicalName, aliases, company, mechanism, status, route, populationTags, keyEvents

Open

Key Events

2025-01-01

GN introduced ReSound Enzo IA as a rechargeable super-power hearing aid for severe-to-profound hearing loss

Related Programs

Apple AirPods Pro Hearing Health Features

Company: Apple · Hearing Aid/Software · Marketed

Nuance Audio Hearing Aid Software